Skip to main content

Table 1 Children characteristics

From: Physiological effects of invasive ventilation with neurally adjusted ventilatory assist (NAVA) in a crossover study

Child

1

2

3

4

5

6

Gender

M

M

M

F

F

F

Age (mo)

3

13

4

10

6

11

Weight (kg)

5.7

8.9

7.0

6.0

5.8

7.0

Cardiopathy

AVSD

VSD with pulmonary stenosis

tetralogy of Fallot

atrial septal defect

coarctation of the aorta

pulmonary atresia with VSD

Cardiopulmonary bypass duration (min)

96

83

130

48

0

130

Time between PICU entry and study (hours)

20

7

20

4

5

7

Baseline cardiac index (L/min.m2)

2.00

2.85

1.93

2.60

2.75

1.85

Milrinone (mcg/kg/min)

0.9

0.5

0.3

0.5

0

0.5

Adrenaline (mcg/kg/min)

0

0

0

0

0

0.05

ScvO2 (%)

64

63

52

82

68

52

Perfusion index (%)

0.31

3.65

0.60

3.62

1.90

0.87

Random order

CV then NAVA

NAVA then CV

CV then NAVA

CV then NAVA

NAVA then CV

NAVA then CV

  1. All children were receiving morphine 0.5 mg per kilo per day. All, except the 2 first, were receiving midazolam 40 micrograms per kilo per hour
  2. AVSD atrioventricular septal defect, VSD ventricular septal defect, NAVA neurally adjusted ventilatory assist, CV conventional ventilation, ScvO2: central venous oxygen saturation